KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Colgate Palmolive (CL) Other Operating Expenses: 2013-2025

Historic Other Operating Expenses for Colgate Palmolive (CL) over the last 12 years, with Sep 2025 value amounting to -$19.0 million.

  • Colgate Palmolive's Other Operating Expenses rose 36.67% to -$19.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$81.0 million, marking a year-over-year increase of 62.50%. This contributed to the annual value of -$164.0 million for FY2024, which is 14.14% up from last year.
  • Latest data reveals that Colgate Palmolive reported Other Operating Expenses of -$19.0 million as of Q3 2025, which was up 26.92% from -$26.0 million recorded in Q2 2025.
  • Colgate Palmolive's 5-year Other Operating Expenses high stood at $33.0 million for Q3 2022, and its period low was -$76.0 million during Q1 2024.
  • For the 3-year period, Colgate Palmolive's Other Operating Expenses averaged around -$37.5 million, with its median value being -$30.0 million (2024).
  • Its Other Operating Expenses has fluctuated over the past 5 years, first tumbled by 400.00% in 2021, then skyrocketed by 265.00% in 2022.
  • Colgate Palmolive's Other Operating Expenses (Quarterly) stood at -$25.0 million in 2021, then climbed by 28.00% to -$18.0 million in 2022, then crashed by 316.67% to -$75.0 million in 2023, then surged by 69.33% to -$23.0 million in 2024, then surged by 36.67% to -$19.0 million in 2025.
  • Its Other Operating Expenses stands at -$19.0 million for Q3 2025, versus -$26.0 million for Q2 2025 and -$13.0 million for Q1 2025.